Pulmonx

A would-be pulmonary pioneer enters the market via intubation.

The last 40 years have brought no major technological advances to intubation, the process of placing a tube in the trachea of a person with a medical need to secure an airway, says Peter Soltesz, a co-founder of Palo Alto, CA-based Pulmonxand its COO. Some 58 million intubations are performed annually worldwide, he says. Normally, the procedure is done quickly, without any complication. However, in many cases, the medical staffer performing an intubation cannot see what he or she is doing, and must proceed guided only by feel and sense of timing. The inability to visualize the anatomy can cause problems: tubes can, for instance, be misplaced in the esophagus or mainstem bronchus, which can lead to morbidity or death if undetected. Trouble happens, Soltesz says, in up to 10% of the emergency intubations performed outside of the hospital in the US each year. Even in calmer operating-room settings, where highly-experienced anesthesiologists typically perform the procedure, intubation can still cause problems 3-5% of the time—if, for instance, a patient turns out to have unusual anatomy. Intubation and tube positioning in infants and neonates are often difficult, simply because their airways are so small.

Pulmonx founders Rod Perkins, Peter Soltesz and Robert Kotmel figured the difficulties of intubation added up to a business opportunity,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By 

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.

Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist

 

Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.

Ellipsis Raises $45M To Expand AI Care Manager Across Health Systems

 
• By 

Ellipsis said it will use its new funding to expand its AI-powered voice assistant Sage across health systems. Ellipsis is part of the global vocal biomarker market, which is expected to exceed $9bn by the end of 2033, according to a research market report.

More from Business

Veterinary Heart Health Goes High-Tech: Eko And Boehringer Use AI To Spot Heart Murmurs In Dogs

 
• By 

Eko hopes its new partnership with Boehringer Ingelheim to develop algorithms for accurately detecting heart murmurs in dogs will pave the way for more collaborations with medical and pharmaceutical companies to advance early detection in humans as well as animals.

Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist

 

Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.

Ellipsis Raises $45M To Expand AI Care Manager Across Health Systems

 
• By 

Ellipsis said it will use its new funding to expand its AI-powered voice assistant Sage across health systems. Ellipsis is part of the global vocal biomarker market, which is expected to exceed $9bn by the end of 2033, according to a research market report.